author-photo

Jv Apala

3

Papers

28

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer

2018 Nature Communications
Show All
- Source
- Cite
- Save
Citations (25)
Abstract OT2-07-02: CNIO-BR-009 trial: Targeting mitochondrial metabolism with ME-344 in breast cancer upon bevacizumab-induced vascular normalization: A phase 0 randomized clinical trial

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abrogation of resistance against bevacizumab (Bev) by mitochondrial inhibition: A phase 0 randomized trial of Bev plus ME344 or placebo in early HER2-negative breast cancer (HERNEBC).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)